small molecule preclinical development candidate | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

52,613 results for “small molecule preclinical development candidate”

Trials

View all 23815 →

Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug

30 participants · First posted Oct 20, 2021

Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.

20 participants · First posted May 5, 2008

Small Molecule LCDM and GV Oocyte

250 participants · First posted May 2, 2022

Drugs

View all 712 →

repurposed small molecule

small molecule program

small molecule HDAC inhibitors (Oncoholdings)

Organizations

View all 897 →

Molecule X LLC

Mexico

A&A SMALL CHANGES HANDYPEOPLE

United States

NEURODX DEVELOPMENT

United States

News

View all 27189 →

Evotec and Almirall Advance First Dermatology Drug Candidate in Record Time Using AI-Driven Platform

IRA Impact: CDMOs Adapt to Navigate Small Molecule Drug Development Challenges

Bipartisan EPIC Act Seeks to Eliminate IRA's Small Molecule Drug Development Disincentive

Page 1 of 5262